Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
The Journal of Thoracic and Cardiovascular Surgery|March 7, 2024
Reversibility of precapillary pulmonary hypertension and outcomes after heart transplantation bridged with left ventricular assist devices: Insight from the United Network for Organ SharingHilmi Alnsasra, Radha Kanneganti Perue, Fouad Khalil, et al.
Frontiers in Pharmacology|April 3, 2024
Dapagliflozin versus sacubitril-valsartan for heart failure with mildly reduced or preserved ejection fractionRonen Arbel, Abed N Azab, Mansi Oberoi, et al.
Frontiers in Cardiovascular Medicine|November 6, 2023
Sex differences in ventricular arrhythmia, atrial fibrillation and atrioventricular block complicating acute myocardial infarctionHilmi Alnsasra, Gal Tsaban, Jean Marc Weinstein, et al.
Atherosclerosis|January 18, 2023
Nonobstructive coronary atherosclerosis is associated with adverse prognosis among patients diagnosed with myocardial infarction without obstructive coronary arteriesGal Tsaban, Ido Peles, Orit Barrett, et al.
ESC Heart Failure|January 15, 2022
Outcomes after heart transplantation in patients with cardiac sarcoidosisRabea Asleh, Alexandros Briasoulis, Ilias Doulamis, et al.
The American Journal of Cardiology|September 3, 2017
Contemporary Determinants of Delayed Benchmark Timelines in Acute Myocardial Infarction in Men and WomenHilmi Alnsasra, Doron Zahger, Diklah Geva, et al.
Frontiers in Pharmacology|August 21, 2023
Dapagliflozin versus empagliflozin in patients with chronic kidney diseaseHilmi Alnsasra, Gal Tsaban, Adam Solomon, et al.
Biomedicines|March 29, 2023
Vascular Function in Continuous Flow LVADs: Implications for Clinical PracticeFouad Khalil, Rabea Asleh, Radha Kanneganti Perue, et al.
Journal of Cardiac Failure|December 9, 2024
Treatment With mTOR Inhibitors as Primary Immunosuppression After Combined Heart and Kidney TransplantationHilmi Alnsasra, Rabea Asleh, Fouad Khalil, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 17, 2023
Effect of Dapagliflozin Versus Empagliflozin on Cardiovascular Death in Patients with Heart Failure Across the Spectrum of Ejection Fraction: Cost per Outcome AnalysisHilmi Alnsasra, Gal Tsaban, Adam Solomon, et al.
Pageof 4